| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |